+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Iodine-131"

From
From
From
From
From
Systemic Radiotherapy - Global Strategic Business Report - Product Thumbnail Image

Systemic Radiotherapy - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
From
Radiotheranostics - Global Strategic Business Report - Product Thumbnail Image

Radiotheranostics - Global Strategic Business Report

  • Report
  • February 2025
  • 168 Pages
  • Global
From
Nuclear Medicine Radioisotopes Global Market Report 2024 - Product Thumbnail Image

Nuclear Medicine Radioisotopes Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report 2025 - Product Thumbnail Image

Radiopharmaceutical Theranostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Radiotheranostics Market Report 2025 - Product Thumbnail Image

Radiotheranostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Radiopharmaceutical Market - Product Thumbnail Image

Radiopharmaceutical Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
Loading Indicator

Iodine-131 (I-131) is a radioactive isotope of iodine used in nuclear medicine and radiopharmacology. It is used to diagnose and treat a variety of conditions, including thyroid cancer, hyperthyroidism, and Graves' disease. I-131 is also used to treat certain types of cancer, such as lymphoma and neuroblastoma. It is administered orally, intravenously, or by inhalation. The radiation emitted by I-131 is absorbed by the body and used to destroy cancer cells. I-131 is produced in nuclear reactors and cyclotrons. It is then purified and formulated into a variety of products, such as capsules, solutions, and suspensions. These products are then distributed to hospitals, clinics, and other healthcare facilities. The I-131 market is highly regulated, with strict safety and quality standards in place. The market is also subject to fluctuations in supply and demand, as well as changes in the cost of production. Some companies in the I-131 market include GE Healthcare, Mallinckrodt Pharmaceuticals, Jubilant Radiopharma, and Bracco Diagnostics. Show Less Read more